USE OF 2-(3,4-DIMETHOXYCINNAMOYL)AMINOBENZOIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF RESTENOSIS

摘要

A method for treating patients to inhibit restenosis associated with coronary intervention, which comprises administering compounds of the class of aminobenzoic acids, specifically 2-(3,4-dimethoxy-cinnamoyl)-aminobenzoic acid or its pharmaceutically acceptable salt at a dosage which is sufficient to maintain the plasma concentration at about 100 mu molar for a period of time of less than three months.